看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | Yes |
| Is net profit margin increasing? | No | No |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Harrow, Inc. |
| Tarsus Pharmaceuticals, Inc. |
| Omeros Corporation |
| Bausch Health Companies Inc. |
| Corcept Therapeutics Incorporated |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| HROW | TARS | OMER | BHC | CORT | OCUL | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -50% | -55% | NA | 4% | 24% | -95% | ||
| Fiscal Year - 1 | -72% | -70% | NA | 69% | 21% | -128% | ||
| Fiscal Year - 2 | -96% | -35% | NA | 56% | 23% | -115% | ||
| Fiscal Year - 3 | -12% | -8% | NA | -442% | 25% | -8% | ||
| Fiscal Year - 4 | 1% | NA | NA | -70% | 24% | -430% | ||
| Fiscal Year - 5 | 107% | NA | 246% | -94% | 29% | -536% | ||
| Average | -21% | -42% | 246% | -79% | 24% | -219% | ||
| Median | -31% | -45% | 246% | -33% | 24% | -121% | ||
| Benchmarks | Ticker | |||||||
| Harrow, Inc. | NasdaqGM:HROW | |||||||
| Tarsus Pharmaceuticals, Inc. | NasdaqGS:TARS | |||||||
| Omeros Corporation | NasdaqGM:OMER | |||||||
| Bausch Health Companies Inc. | NYSE:BHC | |||||||
| Corcept Therapeutics Incorporated | NasdaqCM:CORT | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | HROW | TARS | OMER | BHC | CORT | OCUL | ||
| Latest Fiscal Year | Dec-23 | Dec-24 | Dec-23 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Sep-24 | Dec-24 | Sep-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 169 | 183 | NA | 9,625 | 675 | 64 | ||
| Fiscal Year | 130 | 183 | NA | 9,625 | 675 | 64 | ||
| Fiscal Year - 1 | 89 | 17 | NA | 8,757 | 482 | 58 | ||
| Fiscal Year - 2 | 72 | 26 | NA | 8,124 | 402 | 51 | ||
| Fiscal Year - 3 | 49 | 57 | NA | 8,434 | 366 | 44 | ||
| Fiscal Year - 4 | 51 | NA | NA | 8,027 | 354 | 17 | ||
| Fiscal Year - 5 | 41 | NA | 30 | 8,601 | 306 | 4 | ||
| Net Income | ||||||||
| Latest Twelve Months | (33) | (116) | (185) | (46) | 140 | (194) | ||
| Fiscal Year | (24) | (116) | (175) | (46) | 140 | (194) | ||
| Fiscal Year - 1 | (14) | (136) | (182) | (592) | 105 | (81) | ||
| Fiscal Year - 2 | (18) | (62) | (192) | (225) | 101 | (71) | ||
| Fiscal Year - 3 | (3) | (14) | (173) | (948) | 113 | (7) | ||
| Fiscal Year - 4 | 0 | (27) | (147) | (560) | 106 | (156) | ||
| Fiscal Year - 5 | 15 | (5) | (127) | (1,788) | 94 | (86) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 286 | 265 | 493 | 27,350 | 622 | 252 | ||
| Latest Fiscal Quarter | 352 | 377 | 313 | 26,523 | 841 | 458 | ||
| Fiscal Year | 312 | 377 | 378 | 26,523 | 841 | 458 | ||
| Fiscal Year - 1 | 157 | 265 | 591 | 27,350 | 622 | 252 | ||
| Fiscal Year - 2 | 98 | 228 | 419 | 25,686 | 583 | 149 | ||
| Fiscal Year - 3 | 57 | 179 | 181 | 29,202 | 424 | 205 | ||
| Fiscal Year - 4 | 59 | 172 | 137 | 31,199 | 572 | 262 | ||
| Fiscal Year - 5 | 49 | 58 | 96 | 33,863 | 412 | 79 | ||
| Fiscal Year - 6 | 24 | 2 | 116 | 32,492 | 312 | 73 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 76 | 197 | (14) | (1,022) | 507 | 91 | ||
| Latest Fiscal Quarter | 58 | 225 | (154) | (1,279) | 680 | 315 | ||
| Fiscal Year | 71 | 225 | (25) | (1,279) | 680 | 315 | ||
| Fiscal Year - 1 | 28 | 197 | 86 | (1,022) | 507 | 91 | ||
| Fiscal Year - 2 | 11 | 193 | 24 | (692) | 502 | 35 | ||
| Fiscal Year - 3 | 27 | 167 | (121) | (106) | 376 | 88 | ||
| Fiscal Year - 4 | 28 | 166 | (109) | 535 | 523 | 76 | ||
| Fiscal Year - 5 | 25 | (6) | (100) | 1,063 | 371 | (4) | ||
| Fiscal Year - 6 | 3 | (1) | (3) | 2,733 | 276 | 36 | ||